Featured Speaker: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University
Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.
In this Webinar we discuss:
CAR-T benefits are T cell dependent
Treatment schema for CAR-T cell therapy
Explore several case studies